There are several different types of meningococcal vaccines, including:
- Menactra and Menveo and MenQuadfi – meningococcal conjugate vaccines that protect against serogroups A, C, W, Y
- Bexsero and Trumenba – meningococcal conjugate vaccines that only protect against serogroup B
- Penbraya – serogroup A, B, C, W, Y meningococcal vaccine
Menomune– an older meningococcal polysaccharide vaccine that protects against serogroups A, C, W, Y (discontinued in 2017)MenHibrix– meningococcal conjugate vaccine that only protect against C, Y and Hib (discontinued in 2016)
Children routinely get their first dose of either Menactra or Menveo or MenQuadfi when they are 11 to 12 years old and a booster at age 16 years.
In addition, “Young adults aged 16 through 23 years (preferred age range is 16 through 18 years) may be vaccinated with either the Bexsero or Trumenba vaccines to provide short-term protection against most strains of serogroup B meningococcal disease.”
More on Meningococcal Vaccines
- At What Age Should Kids Get a Meningococcal Vaccine?
- Meningococcal Disease Outbreaks
- Is the Meningococcal Vaccine More Dangerous Than Meningococcal Disease?
- Understanding the Recommendations to Get a Men B Vaccine
- Vaccines for Kids with Asplenia
- Ask the Experts about Meningococcal Vaccines
- CDC – Meningococcal Vaccination: What Everyone Should Know
- CDC – MCV4 VIS
- CDC – MenB VIS
- Meningococcal ACIP Vaccine Recommendations
- Pinkbook – Meningococcal
- FDA – Menomune (package insert)
- FDA – Menveo (package insert)
- FDA – Menactra (package insert)
- FDA – Menhibrix (package insert)
- FDA – Bexsero (package insert)
- FDA – Trumenba (package insert)
- A Look at Each Vaccine : Meningococcal
- History of the Meningococcal Vaccines
- Meningococcal Disease Facts and Stories